NewRocket GmbH is a aerospace company founded by two researchers from the Technical University of Munich. Currently, the company employs 18 people, including the founders. To finance the first small batch production line, the founders decide to raise their seed round from professional investors. To cover the expected expenses of the next 24 months, the founding team decides to raise 6 Mn. € of external capital. After several weeks of close exchange and negotiations with potential investors, the single seed investor AlphaStar is willing to sign a term sheet at a 18 Mn. € pre-money valuation. The 30.000 founding shares are distributed among the founders according to the initial capital they've provided to fund the first months of research and product development prior to the seed round. Since the second founder provided only a third of the initial capital, 10.000 of the founding shares are assigned to her. Eighteen months after raising their seed round, the team has grown to 38 people and is eager to start the serial production of their production line. To fund the upcoming cost, the founders decide to raise a series A financing round. After assessing multiple term sheets, the founders sign a term sheet with Betaplus Capital over an investment amount of 12 Mn. € at a 40 Mn. € pre-money valuation. Now assume NewBios' efforts after the seed round wouldn't have been successful. Therefore, to save the company, instead of the A-round, they would have raised a down round from Delta Invest of 4 Mn. € at a pre-money valuation of 10 Mn. €. Moreover, assume in this case that AlphaStar has negotiated a weighted average ratchet anti-dilution protection. How many free shares (rounded to the nearest integer) are issued to AlphaStar due to the down round? Question 55Answer a. 2,000.00 shares b. None of the given answers is correct. c. 7,353.00 shares d. 4,730.00 shares